F
Foamix Pharmaceuticals
Profile managed by Bizz IdFoamix (ahora Vyne Therapeutics)
Israel
51-200 employees
2003
Description
Israeli pharmaceutical company specializing in dermatology, acquired by Menlo Therapeutics in 2019 to form Vyne Therapeutics. Developed AMZEEQ® (topical minocycline foam, FDA-approved) for acne. Patented pharmaceutical foam platform.